Showing results (61-70 of 237) with videos related to
Sort By:
Pageof 24
Vox Sanguinis|November 29, 2018
Fear of blood, injections and fainting as barriers to blood donation in BrazilMiriane Lucindo Zucoloto, Thelma Gonçalez, Neia Prata Menezes, et al.Transfusion|December 16, 2010
Donor return after temporary deferralBrian Custer, Karen S Schlumpf, David Wright, et al.Journal of Medical Economics|November 26, 2011
Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysisHuseyin Naci, Gregory de Lissovoy, Christopher Hollenbeak, et al.Transfusion|September 29, 2011
Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year periodBrian Custer, Karen Schlumpf, Toby L Simon, et al.Transfusion Medicine Reviews|September 23, 2023
HIV Pre-Exposure Prophylaxis, Blood Donor Deferral, Occult Infection, and Risk of HIV Transmission by Transfusion: A Fine Balance Between Evidence-Based Donor Selection Criteria and Transfusion SafetyJean-François Leblanc, Brian Custer, Thijs Van de Laar, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 15, 2019
Factors that contribute to blood donation behavior among primary healthcare users: A structural approachMiriane L Zucoloto, Thelma T Gonçalez, Philippe T Gilchrist, et al.Journal of Clinical Gastroenterology|December 17, 2004
Global epidemiology of hepatitis B virusBrian Custer, Sean D Sullivan, Thomas K Hazlet, et al.AIDS Research and Human Retroviruses|August 17, 2006
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infectionPhilip J Norris, Brandee L Pappalardo, Brian Custer, et al.Transfusion|June 21, 2011
Adverse reactions and other factors that impact subsequent blood donation visitsBrian Custer, Jorge A Rios, Karen Schlumpf, et al.Transfusion|January 8, 2022
Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single-step strategiesKatherine M Prioli, Ilze Abersone, Patricia M Kopko, et al.Pageof 24